With new data on petosemtamab set to be presented at the European Society for Medical Oncology Asia Congress, Merus believes ...

The FDA has approved 43 novel drugs so far this year (January-November), compared to 52 during the same period last year. As we step ...

Perioperative chemotherapy may be underused in patients with stage II-III esophageal cancer, according to researchers.

Novel physicochemical approach to optical biosensing that leverages the unique properties of 1DZnO nanostructures. These ...

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne ...

Petosemtamab 1500 mg monotherapy phase 2 interim data continues to demonstrate clinically meaningful activity in 2L+ HNSCC– Conference call on ...